Analystreport

Nabriva Therapeutics AG (NASDAQ: NBRV) is now covered by analysts at SunTrust Banks, Inc.. They set a "buy" rating on the stock.

Nabriva Therapeutics plc - Ordinary Shares  (NBRV) 
Last nabriva therapeutics plc - ordinary shares earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.nabriva.com/investor-relations